Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 2
2005 6
2006 2
2007 5
2008 7
2009 9
2010 4
2011 1
2012 1
2013 3
2014 6
2015 6
2016 5
2017 11
2018 10
2019 2
2020 9
2021 30
2022 15
2023 14

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Bruix J, Qin S, Merle P, Granito A, Huang YH, Bodoky G, Pracht M, Yokosuka O, Rosmorduc O, Breder V, Gerolami R, Masi G, Ross PJ, Song T, Bronowicki JP, Ollivier-Hourmand I, Kudo M, Cheng AL, Llovet JM, Finn RS, LeBerre MA, Baumhauer A, Meinhardt G, Han G; RESORCE Investigators. Bruix J, et al. Among authors: granito a. Lancet. 2017 Jan 7;389(10064):56-66. doi: 10.1016/S0140-6736(16)32453-9. Epub 2016 Dec 6. Lancet. 2017. PMID: 27932229 Clinical Trial.
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database.
Vitale A, Svegliati-Baroni G, Ortolani A, Cucco M, Dalla Riva GV, Giannini EG, Piscaglia F, Rapaccini G, Di Marco M, Caturelli E, Zoli M, Sacco R, Cabibbo G, Marra F, Mega A, Morisco F, Gasbarrini A, Foschi FG, Missale G, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Oliveri F, Pelizzaro F, Ramirez Morales R, Cillo U, Trevisani F, Miele L, Marchesini G, Farinati F; Italian Liver Cancer (ITA.LI.CA) group. Vitale A, et al. Gut. 2023 Jan;72(1):141-152. doi: 10.1136/gutjnl-2021-324915. Epub 2021 Dec 21. Gut. 2023. PMID: 34933916
COVID-19: Has the Liver Been Spared?
Brandi N, Spinelli D, Granito A, Tovoli F, Piscaglia F, Golfieri R, Renzulli M. Brandi N, et al. Among authors: granito a. Int J Mol Sci. 2023 Jan 6;24(2):1091. doi: 10.3390/ijms24021091. Int J Mol Sci. 2023. PMID: 36674607 Free PMC article. Review.
Tocilizumab: From Rheumatic Diseases to COVID-19.
Raiteri A, Piscaglia F, Granito A, Tovoli F. Raiteri A, et al. Among authors: granito a. Curr Pharm Des. 2021;27(13):1597-1607. doi: 10.2174/1381612827666210311141512. Curr Pharm Des. 2021. PMID: 33719967 Review.
Anti-ganglioside antibodies and celiac disease.
Granito A, Tovoli F, Raiteri A, Volta U. Granito A, et al. Allergy Asthma Clin Immunol. 2021 May 28;17(1):53. doi: 10.1186/s13223-021-00557-y. Allergy Asthma Clin Immunol. 2021. PMID: 34049567 Free PMC article. No abstract available.
Antinuclear antibodies in COVID 19.
Muratori P, Lenzi M, Muratori L, Granito A. Muratori P, et al. Among authors: granito a. Clin Transl Sci. 2021 Sep;14(5):1627-1628. doi: 10.1111/cts.13026. Epub 2021 May 1. Clin Transl Sci. 2021. PMID: 33932091 Free PMC article. No abstract available.
Experience with regorafenib in the treatment of hepatocellular carcinoma.
Granito A, Forgione A, Marinelli S, Renzulli M, Ielasi L, Sansone V, Benevento F, Piscaglia F, Tovoli F. Granito A, et al. Therap Adv Gastroenterol. 2021 May 28;14:17562848211016959. doi: 10.1177/17562848211016959. eCollection 2021. Therap Adv Gastroenterol. 2021. PMID: 34104211 Free PMC article. Review.
Current topics in autoimmune hepatitis.
Muratori L, Muratori P, Granito A, Pappas G, Cassani F, Lenzi M. Muratori L, et al. Among authors: granito a. Dig Liver Dis. 2010 Nov;42(11):757-64. doi: 10.1016/j.dld.2010.05.019. Epub 2010 Jul 7. Dig Liver Dis. 2010. PMID: 20615766 Review.
TKIs in combination with immunotherapy for hepatocellular carcinoma.
Stefanini B, Ielasi L, Chen R, Abbati C, Tonnini M, Tovoli F, Granito A. Stefanini B, et al. Among authors: granito a. Expert Rev Anticancer Ther. 2023 Mar;23(3):279-291. doi: 10.1080/14737140.2023.2181162. Epub 2023 Feb 26. Expert Rev Anticancer Ther. 2023. PMID: 36794716 Review.
129 results